Julianna Lemieux

Mark Munch, president of Bruker Nano Group, talks to GEN about Bruker’s reasons for acquiring Nanostring and their vision for the future.

In an effort to illustrate that genomic surveillance can build the foundation for scaleable precision phage therapy, an international collaboration

Credit: elenabs/ 1189916170/iStock / Getty Images Plus X-linked chronic granulomatous disease (X-CGD) is a rare genetic disorder characterized

Mouse study of therapeutic food for malnourished children reveals new gut bacterial enzyme's wide-ranging functions.

P. aeruginosa makes a trade-off between colonizing and surviving during infection by switching between biofilm formation and a planktonic state.

Antibody Cages (AbCs) array antibodies in three-dimensional space with atomic accuracy over properties such as size, shape, valency, and orientation.

Archon Biosciences emerges from stealth to advance a new class of biologic invented in Nobel Prize-winning computational protein design lab.

We asked several researchers to share their perspectives on ASHG 2024 and the potential impact of the U.S. election results on science and biotech.

ASHG 2024 president, Bruce Gelb, shares themes from the meeting and the science and technologies that will be highlighted.

A team of researchers from around the world has solved the mystery of a child with a rare genetic illness that did not fit any known disease.